Pharma Finance Archive

0

La Jolla Pharmaceutical Company Announces Pricing of Underwritten Offering of Common Stock

La Jolla Pharmaceutical Company , a leader in the development of therapeutics targeting significant unmet life-threatening diseases, today announced the pricing of an underwritten offering of 4,800,000 shares of its common stock, offered at a price of $10.50 per share.
0

Camargo Strengthens Research Team and Therapeutic Expertise

Camargo Pharmaceutical Services, a leading drug development organization specializing in the 505 approval pathway, expands its research team and therapeutic expertise with the addition of Dr.
0

FDA Advisory Committee Meeting Strategies Conference, September 11-12, Virginia

Social Media Implications, Solidifying Data for On-Site Presentation Among Key Topics at FDA Advisory Committee Meeting Strategies ConferenceRegulatory professionals now have the opportunity...
0

Pharmaceutical Pricing and Contracting Conference, September 22-23, 2014, Philadelphia

Drug Pricing Trends, 340-B Regulations Among Sessions and Panel Discussions at Inaugural EventPricing professionals now have the opportunity to network and share ideas on the pharmaceutical...
0

Pharmaceutical and Medical Device Scientific Communications Conference, October 13-14, 2014, Boston

Investigator-Led Research, Timeline and Resource Management Among Session Topics at Inaugural EventFor the first time ever, Q1 Productions is hosting the Pharmaceutical and Medical Device...
0

Healthcare Chief Medical Officer Forum, November 13-14, 2014, Virginia

Q1 Productions Hosting First Ever CMO Meeting Geared Toward Hospital and Healthcare Systems ExecsBy request, Q1 Productions will be hosting the first-ever Healthcare Chief Medical Officer...
0

ISPE Annual Meeting – Preview

As the pharmaceutical landscape evolves,industry professionals are being askedto overcome an increasing number ofchallenges and accomplish more today.
0

Research and Markets: Pipeline Analysis and Sales Projections of the Top 25 Pharmaceutical Companies 2013-2023

Research and Markets has announced the addition of the "Top 25 Pharmaceutical Company Pipeline Analysis and Sales Project
0

Medical Devices Summit Midwest, October 1-2, 2014, Minneapolis

Today most medical devices are part of a larger system and they no longer work as stand-alone items.
0

The human parasite Leishmania is a probiotic for the fly that carries it

The Leishmania parasite, which causes the human disease leishmaniasis, acts as a probiotic in the insect that transmits it to humans, protecting them from bacterial disease.
Page 1 of 1,34712345...102030...Last »